Resilience And ‘Lessons Learned’ Must Be The COVID Legacy In Germany
Executive Summary
The COVID-19 threat is abating and control measures are easing, but government commitments made at the height of the pandemic to forearm against future health care emergencies should not be abandoned. That is the position of both the German Advisory Council on Health and Care and the IVD industry.
You may also be interested in...
German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023
While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.
So The Public Health Emergency Is Over. Now What?
In January, US President Joe Biden announced that the COVID-19 public health emergency will expire in May. Dr. David Feldman, chief medical officer at The Doctors Company, spoke to Medtech Insight about what the official end of the emergency means for average Americans.
Spring Launch For Germany’s Digital Strategy
Interested parties have been consulted, workshop findings noted and online surveys completed; the drafting of Germany’s digital health strategy is now underway.